Catalog
Client
Theme:
0 0
Catalog
Main page
Wishlist
0
Compare
0
Contacts

Mestinon Meda Pharma

Brand: Meda Pharma Product Code: EU12009
0
All about product
Description
Specification
Reviews 0
Questions0
Out Of Stock
€21.00
Acne: No
Active substance: Pyridostigmine Bromide
Also known as: Mestinon, Regonol
Aromatization: No
Blood pressure: Can cause fluctuations, typically lowering blood pressure due to vasodilation
Mestinon Meda Pharma
Mestinon Meda Pharma
€21.00
Description
Specifications
Features
Acne
No
Active substance
Pyridostigmine Bromide
Also known as
Mestinon, Regonol
Aromatization
No
Blood pressure
Can cause fluctuations, typically lowering blood pressure due to vasodilation
Chemical name
3-hydroxy-1-methylpyridinium bromide dimethylcarbamate
Dosage (medical)
Typical starting dose for adults in the treatment of myasthenia gravis is 60 mg taken orally every 4 hours but can vary based on individual patient needs and conditions
Dosage (sports)
Not applicable as it is not legally used to enhance athletic performance
Effects
Improved muscle strength in patients with myasthenia gravis
Formula
C9H13BrN2O2
Half-life
Approximately 1.78 to 2.25 hours
HBR
No
Hepatotoxicity
No
Lab Test
Monitoring of cholinesterase levels may be conducted to assess efficacy and dosage requirements
Main action
Inhibits the breakdown of acetylcholine, thereby increasing its concentration at neuromuscular junctions
Side effects
Nausea, vomiting, diarrhea, abdominal cramps, increased salivation and sweating, muscle cramps, and twitching
Storage conditions
Store at room temperature away from moisture and heat
Substance class
Acetylcholinesterase inhibitor
Trade name
Mestinon, Regonol
Use in sports
Not used or recommended
WAREHOUSE
International Warehouse 2
Water Retention
No
Manufacturer
Meda Pharma
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.